Lupin, Jubilant launch Diovan copy as Ranbaxy exclusivity ends – dnaindia.com

0

After Ranbaxy, three more domestic (Indian) pharmaceutical companies – Lupin, Aurobindo Pharma and Jubilant Life Sciences – have received final approval from the US drug regulator to sell generic valsartan in the US market.

The drug is used to treat hypertension and to lower blood pressure.

Read more – dnaindia.com

 

share >>>
January 7, 2015 |

Leave a Reply

Vantage Theme – Powered by WordPress.
Skip to toolbar